| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVH | Class A Common Stock | Tax liability | -$257K | -28.5K | -6.93% | $8.99 | 383K | Mar 1, 2025 | Direct | F1, F2 |
| transaction | EVH | Class A Common Stock | Award | $0 | +235K | +61.3% | $0.00 | 618K | Mar 3, 2025 | Direct | F2, F3, F4 |
| transaction | EVH | Class A Common Stock | Award | $0 | +161K | +26.09% | $0.00 | 780K | Mar 3, 2025 | Direct | F2, F5 |
| transaction | EVH | Class A Common Stock | Tax liability | -$638K | -72.8K | -9.33% | $8.77 | 707K | Mar 3, 2025 | Direct | F2, F6 |
| Id | Content |
|---|---|
| F1 | This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. |
| F2 | Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| F3 | Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. |
| F4 | Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028. |
| F5 | Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2024. |
| F6 | This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units. |